Aprepitant for the Treatment of Pruritus in S ézary Syndrome

This randomized clinical trial assesses whether treatment with the neurokinin 1 receptor antagonist aprepitant decreases pruritus vs placebo in patients with S ézary syndrome.
Source: JAMA Dermatology - Category: Dermatology Source Type: research